Meanwhile, Kehlet et al. (2017) [45] also quantified cathepsin S-degraded Decorin from serum samples taken from lung cancer patients and developed a promising assay with a diagnostic power of 0.96 in disease patients (against 0.77 from healthy individuals). Here, CTSS is linked to lung carcinoma.